http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007096633-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_318df6200066fe171093cfab6b13a9ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99dfdd02bcde8ca0dc96c2777083c0e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4490e11ecc4ae51173394689297949b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91eafc59b4d604221210185050157959
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0da7ef806e46523acd5717bcc068eddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5812751ef1c617ece05f83c53608eb38
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2828
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
filingDate 2007-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b31d3f4979b5a4079c85abd0ab00f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e5ed9a7346cd0933d676b922032e9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19d6f2bc623595bf040f9bed14e4923a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d046c98edde94f6fc35cb3ce6c1c60c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eadd70adeb2462cd4412e64085a8a3a
publicationDate 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007096633-A1
titleOfInvention Infectivity assay
abstract There is provided a method for infecting a target cell with a TSE agent, comprising: i) contacting said target cell with a membrane preparation, wherein the membrane preparation comprises the TSE agent and a donor membrane; and ii) infecting said target cell with the TSE agent. There is also provided a contiguous membrane, comprising a donor membrane and a membrane containing a TSE agent, wherein the TSE agent is selected from the group consisting of CJD, vCJD, familial CJD (eg. FFI or CSS), iatrogenic CJD, BSE, ovine BSE, and CWD.
priorityDate 2006-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0224871-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129204988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135879102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129672457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33022

Total number of triples: 52.